{"id":1341,"date":"2013-12-11T01:09:34","date_gmt":"2013-12-11T00:09:34","guid":{"rendered":"http:\/\/stg-blogs.bmj.com\/injury-prevention\/?p=1341"},"modified":"2013-12-11T01:09:34","modified_gmt":"2013-12-11T00:09:34","slug":"nobel-prize-winner-criticizes-elite-journals","status":"publish","type":"post","link":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/2013\/12\/11\/nobel-prize-winner-criticizes-elite-journals\/","title":{"rendered":"Nobel prize-winner criticizes elite journals"},"content":{"rendered":"<p><a title=\"\" href=\"http:\/\/www.theguardian.com\/commentisfree\/2013\/dec\/09\/how-journals-nature-science-cell-damage-science\">Writing in the Guardian<\/a>, (Nobel prize winner) Schekman raises serious concerns over some journals&#8217; practices and calls on others in the scientific community to take action.\u00a0&#8220;I have published in the big brands, including papers that won me a Nobel prize. But no longer,&#8221; he writes. &#8220;Just as Wall Street needs to break the hold of bonus culture, so science must break the tyranny of the luxury journals.&#8221;\u00a0Schekman is the editor of\u00a0<a title=\"\" href=\"http:\/\/www.elifesciences.org\/\">eLife<\/a>, an online journal set up by the Wellcome Trust. Articles submitted to the journal \u2013 a competitor to Nature, Cell and Science \u2013 are discussed by reviewers who are working scientists and accepted if all agree. The papers are free for anyone to read.<\/p>\n<p>Schekman criticises Nature, Cell and Science for artificially restricting the number of papers they accept, a policy he says stokes demand &#8220;like fashion designers who create limited-edition handbags.&#8221; He also attacks a widespread metric called an &#8220;impact factor&#8221;, used by many top-tier journals in their marketing.\u00a0A journal&#8217;s impact factor is a measure of how often its papers are cited, and is used as a proxy for quality. But Schekman said it was &#8220;toxic influence&#8221; on science that &#8220;introduced a distortion&#8221;. He writes: &#8220;A paper can become highly cited because it is good science &#8211; or because it is eye-catching, provocative, or wrong.&#8221;<\/p>\n<p><a title=\"\" href=\"http:\/\/mcb.berkeley.edu\/labs\/schekman\/pages\/lab%20members.html\">Daniel Sirkis<\/a>, a postdoc in Schekman&#8217;s lab, said many scientists wasted a lot of time trying to get their work into Cell, Science and Nature. &#8220;It&#8217;s true I could have a harder time getting my foot in the door of certain elite institutions without papers in these journals during my postdoc, but I don&#8217;t think I&#8217;d want to do science at a place that had this as one of their most important criteria for hiring anyway,&#8221; he told the Guardian.<\/p>\n<p>For more of what was written go to :<\/p>\n<p>http:\/\/www.theguardian.com\/science\/2013\/dec\/09\/nobel-winner-boycott-science-journals\/print<\/p>\n<p><span style=\"text-decoration: underline\">Editors comment<\/span>: I would have liked to see more evidence that these journals, his competitors, are truly guilty of the behaviour he alleges, but I suspect it is true. I do wonder, however, why he did not take this stand before winning the Nobel prize, but that may well be sour grapes. I don&#8217;t think this is much of a problem in our field and I am confident that Injury Prevention chooses papers to &#8216;stoke demand&#8217;.<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Writing in the Guardian, (Nobel prize winner) Schekman raises serious concerns over some journals&#8217; practices and calls on others in the scientific community to take action.\u00a0&#8220;I have published in the big brands, including papers that won me a Nobel prize. But no longer,&#8221; he writes. &#8220;Just as Wall Street needs to break the hold of [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/stg-blogs.bmj.com\/injury-prevention\/2013\/12\/11\/nobel-prize-winner-criticizes-elite-journals\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2574],"tags":[],"class_list":["post-1341","post","type-post","status-publish","format-standard","hentry","category-journal-writing"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/posts\/1341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/comments?post=1341"}],"version-history":[{"count":0,"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/posts\/1341\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/media?parent=1341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/categories?post=1341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/injury-prevention\/wp-json\/wp\/v2\/tags?post=1341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}